These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17367980)

  • 1. Impurity profile study of zaleplon.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Kumar MS; Magesh S; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 May; 44(1):101-9. PubMed ID: 17367980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of potential impurities of donepezil.
    Krishna Reddy KV; Moses Babu J; Kumar PA; Chandrashekar ER; Mathad VT; Eswaraiah S; Reddy MS; Vyas K
    J Pharm Biomed Anal; 2004 Sep; 35(5):1047-58. PubMed ID: 15336352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of potential impurities of rabeprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Sudhakar P; Babu JM; Vyas K; Reddy PR; Mukkanti K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1262-9. PubMed ID: 17134865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, structural elucidation and characterization of impurities in Cefdinir.
    Rao KV; Rani A; Reddy AV; Bharathi CH; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Mar; 43(4):1476-82. PubMed ID: 17174507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, isolation and characterization of potential degradation product in risperidone tablets.
    Bharathi Ch; Chary DK; Kumar MS; Shankar R; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Jan; 46(1):165-9. PubMed ID: 17981421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impurity profile study of repaglinide.
    Reddy KV; Babu JM; Mathad VT; Eswaraiah S; Reddy MS; Dubey PK; Vyas K
    J Pharm Biomed Anal; 2003 Jul; 32(3):461-7. PubMed ID: 14565550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of potential impurities of amlodipine maleate.
    Sudhakar P; Nirmala M; Moses Babu J; Vyas K; Madhusudan Reddy G; Vijaya Bhaskar B; Pratap Reddy P; Mukkanti K
    J Pharm Biomed Anal; 2006 Feb; 40(3):605-13. PubMed ID: 16324814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural identification and characterization of potential impurities of pantoprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Ashok S; Sudhakar P; Babu JM; Vyas K; Mukkanti K
    J Pharm Biomed Anal; 2007 Oct; 45(2):201-10. PubMed ID: 17629653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural identification and characterization of impurities in moxifloxacin.
    Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS
    J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of spectrophotometric, densitometric, and HPLC techniques as stability indicating methods for determination of Zaleplon in pharmaceutical preparations.
    Metwally FH; Abdelkawy M; Abdelwahab NS
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Dec; 68(5):1220-30. PubMed ID: 17353143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of new impurity in didanosine.
    Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor.
    Satyanarayana U; Rao DS; Kumar YR; Babu JM; Kumar PR; Reddy JT
    J Pharm Biomed Anal; 2004 Jun; 35(4):951-7. PubMed ID: 15193741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Separation and identification of impurities from intermediates of istradefylline].
    Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M
    Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impurity profile study of loratadine.
    Reddy KV; Babu JM; Kumar YR; Reddy SV; Kumar MK; Eswaraiah S; Reddy KR; Reddy MS; Bhaskar BV; Dubey PK; Vyas K
    J Pharm Biomed Anal; 2003 Apr; 32(1):29-39. PubMed ID: 12852446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of process-related impurities in linezolid.
    Krishna Reddy KV; Mahender Rao S; Om Reddy G; Suresh T; Moses Babu J; Dubey PK; Vyas K
    J Pharm Biomed Anal; 2002 Oct; 30(3):635-42. PubMed ID: 12367688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits.
    Noguchi H; Kitazumi K; Mori M; Shiobara Y; Shiba T
    J Pharmacol Sci; 2003 Oct; 93(2):204-9. PubMed ID: 14578589
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.